Clinical trials
Phase 3 Urinary Bladder Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Europe Ltd. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bioniche Life Sciences Inc. | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Diseases | 5 |
| Urologic Diseases | 4 |
| Carcinoma, Transitional Cell | 3 |
| Neoplasms | 3 |
| Neoplasms by Site | 3 |
| Urinary Bladder Neoplasms | 3 |
| Urogenital Neoplasms | 3 |
| Urologic Neoplasms | 3 |
| Carcinoma in Situ | 2 |
| Cystitis, Interstitial | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.